| Financial Year |
March 31 2023 |
| Monetary Funds |
811,344,983.23 |
| Held-for-trading Financial Assets |
28,945,794.31 |
| Notes Receivable |
97,686,945.50 |
| Accounts Receivable |
1,250,571,955.93 |
| Advances to Suppliers |
174,547,288.27 |
| Other Receivables |
27,767,120.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
463,758,392.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,091,848.53 |
| Total Current Assets |
3,500,814,521.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,328,302.58 |
| Investment Properties |
31,397,367.95 |
| Fixed Assetes |
840,716,089.17 |
| Under-construction Projects |
307,379,393.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,025,533.45 |
| R&D expenses |
-- |
| Goodwill |
1,261,840.28 |
| Long-Term Deferred and Prepaid Expenses |
1,366,108.33 |
| Deferred Income Tax Assets |
52,997,417.78 |
| Other Non-Current Assets |
17,392,514.11 |
| Sub-Total of Non-Current Assets |
1,473,173,807.54 |
| Total Assets |
4,973,988,329.52 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
441,040,700.51 |
| Accounts Payable |
1,080,248,952.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,230,431.62 |
| Taxes Payable |
38,978,394.56 |
| Interest Payable |
-- |
| Dividend Payable |
75,223,223.17 |
| Other payables |
138,185,947.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,770,734.64 |
| Other Current Liabilities |
101,300,746.16 |
| Sub-Total of Current Liabilities |
2,184,982,699.03 |
| Long-term Loans |
250,520,161.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,752,710.83 |
| Deferred Income Tax Liabilities |
8,626,730.63 |
| Other Non-Current Liabilities |
2,839,003.70 |
| Sub-Total of Non-Current Liabilities |
294,176,798.05 |
| Total Liabilities |
2,479,159,497.08 |
| Paid-In Capital(Or Share Stock) |
610,500,000.00 |
| Capital Surplus |
61,186,504.43 |
| Surplus Reserve |
132,760,346.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,242,090,914.62 |
| Minority Stockholder's Interest |
424,008,431.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,070,820,400.59 |
| Owner's Equity（Stockholder's Equity） |
2,494,828,832.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,973,988,329.52 |
